| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
1.76 0.04 (0.02%) |
03-22 16:00 |
|
Open: |
1.7 |
Pre close: |
1.72 |
Target:
|
2.28
|
|
High: |
1.8 |
Low: |
1.7 |
Resistance:
|
1.95
2.28
|
|
Volume: |
280,972 |
Market Cap: |
100M |
Support:
|
1.55
1.30
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.76
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
1.65  |
Signal(12,26,9): |
0.09 |
|
MA(100): |
1.47 |
Stochastic Oscillator |
%K(14,3):
|
63.79 |
|
MA(250): |
1.85 |
%D(3): |
66.86 |
|
Average Volume(K) |
3-Month: |
25341
|
52-Week |
High:
|
2.92 |
|
10-Days: |
36886 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
59.37 |
Change(%): |
-20.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.210 |
Return on Equity (ttm) |
-18.3 |
Shares Out. (M) |
56.87 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-15.9 |
Shares Float (M) |
54.05 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.03 |
% Held by Insiders |
5.00 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
59.90 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.820 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.38 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.97 |
|
Profit Margin |
-13.79 |
Operating Cash Flow
(M) |
-4.71 |
P/S |
250228000.00 |
|
Operating Margin |
-53.87 |
Levered Free Cash Flow
(M) |
-5.65 |
P/CF |
-21.25 |
|
|
|
|
|
|
